Skip to content

Evaluation of the effect of Carrogated drain in reducing SSI

Evaluation of the effect of subcutaneous implantation of Corrugated drain in reducing the incidence of surgery side infection in patient with midline incision

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201022049115N1
Enrollment
158
Registered
2021-05-14
Start date
2020-01-21
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Acute abdomen. Condition 2: Acut peritonitis. Condition 3: Biliary peritonitis. Condition 4: Fecal peritonitis. Acute abdomen Peritonitis Peritonitis Peritonitis

Interventions

Intervention 1: Intervention group: Patients with subcutaneous fat thickness greater than 20 mm who underwent pre-suture subcutaneous Corrugated drain implantation in emergency open midline laparotomy

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with acute peritonitis who have undergone acute midline incision surgery Patients with biliary peritonitis, fecal peritonitis, or patients with obvious pus in the peritoneal cavity Patients with subcutaneous fat thickness of more than 20 mm

Exclusion criteria

Exclusion criteria: Patients under 18 years old and over 70 years old Patients who do not consent to participate in the study Patients who undergo surgery with incisions other than midline incisions (McBurney incision, cochlear incision, paramedin incision, etc.) Pregnant patients Immune deficiency patients (patients with HIV positive serology, patients undergoing immunosuppressive therapy and patients undergoing any chemotherapy in the last 3 months) Patients for whom any other implant except drain is implanted (including meshplasty, etc.) Patients who do not visit the clinic at the appointed times for follow up Patients with a subcutaneous fat thickness of less than 20 mm Patients with other types of peritonitis (pancreatic peritonitis, etc.)

Design outcomes

Primary

MeasureTime frame
Surgical site infection. Timepoint: Evaluation of surgical site infection daily during hospitalization and also at the time of patients' visit to the hospital clinic up to 30 days after surgery. Method of measurement: Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIman Aminian

Tehran University of Medical Sciences

Imanaminian64@gmail.com+98 21 2293 4032

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026